139 related articles for article (PubMed ID: 22076510)
21. The Court of Justice of the European Union changes its case law on patentability of human embryonic stem cells.
Bonadio E; Rovati AM
Rev Derecho Genoma Hum; 2015; (42):161-7. PubMed ID: 26665350
[TBL] [Abstract][Full Text] [Related]
22. No patent-no therapy: a matter of moral and legal consistency within the European Union regarding the use of human embryonic stem cells.
Faltus T
Stem Cells Dev; 2014 Dec; 23 Suppl 1():56-9. PubMed ID: 25457964
[TBL] [Abstract][Full Text] [Related]
23. Fresh hope for German stem-cell patent case.
Abbott A
Nature; 2009 Nov; 462(7271):265. PubMed ID: 19924182
[No Abstract] [Full Text] [Related]
24. How changes in patent law may affect doctor inventors.
Kim AZ
World Neurosurg; 2010 Dec; 74(6):552-3. PubMed ID: 21492613
[No Abstract] [Full Text] [Related]
25. Patent protection for stem cell procedures under the law of the European Union.
Spranger TM
Med Etika Bioet; 2003; 10(1-2):4-8. PubMed ID: 16294439
[TBL] [Abstract][Full Text] [Related]
26. The author file: Oliver Brüstle.
Baker M
Nat Methods; 2012 Jun; 9(6):519. PubMed ID: 22874977
[No Abstract] [Full Text] [Related]
27. ACOG Committee Opinion. Number 364 May 2007. Patents, medicine, and the interests of patients.
Committees on Ethics and Genetics of American College of Obstetricians and Gynecologists
Obstet Gynecol; 2007 May; 109(5):1249-54. PubMed ID: 17470613
[TBL] [Abstract][Full Text] [Related]
28. The impact of European embryonic stem cell patent decisions on research strategies.
Mahalatchimy A; Rial-Sebbag E; Duguet AM; Taboulet F; Cambon-Thomsen A
Nat Biotechnol; 2015 Jan; 33(1):41-3. PubMed ID: 25574634
[No Abstract] [Full Text] [Related]
29. Embryonic stem cell patents at European top court.
den Exter A
Eur J Hum Genet; 2016 Mar; 24(3):311. PubMed ID: 26130487
[No Abstract] [Full Text] [Related]
30. Patenting the obvious?
Check E
Nature; 2007 May; 447(7140):16-7. PubMed ID: 17476235
[No Abstract] [Full Text] [Related]
31. Patents on parts of the human body: salient issues under EC and WTO law.
Herdegen M
J World Intellect Prop; 2002 Mar; 5(2):145-55. PubMed ID: 15986546
[No Abstract] [Full Text] [Related]
32. Patenting of human embryonic stem cells in Europe.
Treichel P
Biotechnol J; 2009 Apr; 4(4):462-4. PubMed ID: 19370720
[No Abstract] [Full Text] [Related]
33. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.
Schrell A; Bauser H; Brunner H
Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818
[TBL] [Abstract][Full Text] [Related]
34. Patents cannot be given for research methods that destroy healthy human embryos to obtain stem cells, German court rules.
Stafford N
BMJ; 2012 Dec; 345():e8248. PubMed ID: 23208269
[No Abstract] [Full Text] [Related]
35. Ethics group advises caution before EC issues stem-cell line patents.
Bosch X
Lancet; 2002 May; 359(9320):1839. PubMed ID: 12044390
[No Abstract] [Full Text] [Related]
36. Considerations in vaccine patent protection.
Brazell L
IDrugs; 2010 Dec; 13(12):885-9. PubMed ID: 21154148
[TBL] [Abstract][Full Text] [Related]
37. European Union joins fight over drug patents.
Watson R
BMJ; 2001 Jul; 323(7303):12. PubMed ID: 11440933
[No Abstract] [Full Text] [Related]
38. Possible clinical usefulness of embryonic stem cells.
Aznar J; Gómez I
Rev Clin Esp; 2012 Sep; 212(8):403-6. PubMed ID: 22765959
[TBL] [Abstract][Full Text] [Related]
39. Brazil and India file complaint against EU over seizure of generic drugs.
Zarocostas J
BMJ; 2010 May; 340():c2672. PubMed ID: 20483945
[No Abstract] [Full Text] [Related]
40. Patents stalemate on biotechnology.
Butler D
Nature; 1994 Dec; 372(6505):393. PubMed ID: 7984224
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
